|
⚲
|
| Specialized Pharmaceuticals Inc | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0001428882 |
| Sale | 2009-01-23 ($1.7 M Offered, $0.8 M Sold) |
| Fund | |
| Phone | 4129313131 |
| Address | 4900 Perry Highway Pittsburgh, 15229 |
| Source | [EDGAR] |
| Fund AUM and Sold ($k) |
|---|
| Fund Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Directors | 2011 - 2025 |
|---|---|
| Michael Huffer | |
| Michael McMahan | |
| Daniel Sassano | |
| Francois Bitz | |
| David Robb | |
| James Smith | |
| Charles Schellhorn |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
KRE MREG Main Line Venture REIT LLC
✚
|
0.0 | |
|
Krepiakevich Terry
✚
|
0.0 | |
|
KRE Quincy REIT Manager LLC
✚
|
0.0 | |
|
Swing Therapeutics, Inc.
✚
|
0.0 | |
|
Swordfish Holdings LLC
✚
|
0.0 | |
|
Swytchboard, Inc.
✚
|
0.0 | |
|
KRE Southline REIT Holdings LLC
✚
|
0.0 | |
|
Krevolin Bret H
✚
|
0.0 | |
|
Krieger Bernd R.
✚
|
0.0 | |
|
Qunnect, LLC
✚
|
0.0 |